300244 迪安診斷
按盤價 
15.260 +0.290 (+1.937%)
15.260 +0.290 (+1.937%) | 2025/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 2,365,126 | -20.45% | 12,196,224 | 13,408,320 | 20,282,469 | 13,082,613 | |
| 減：營業總成本 | 2,246,967 | -19.09% | 11,403,546 | 12,243,282 | 16,603,821 | 11,084,409 | |
| 其中:營業成本 | 1,740,876 | -21.37% | 8,779,607 | 9,213,383 | 12,745,811 | 8,076,949 | |
| 財務費用 | 42,789 | -15.92% | 198,032 | 220,608 | 298,236 | 217,479 | |
| 資產減值損失 | (1,414) | -2.64% | (401,579) | (16,738) | (624,025) | (272,189) | |
| 公允價值變動收益 | 2,565 | -134.31% | (12,697) | (727) | (56,236) | 83,354 | |
| 投資收益 | (6,533) | 239.36% | 38,713 | (17,596) | 48,787 | 55,338 | |
| 其中：對聯營企業和合營企業的投資收益 | (4,168) | 0.60% | 11,584 | (6,722) | 26,763 | 39,785 | |
| 營業利潤 | 23,423 | -77.23% | (31,115) | 842,183 | 2,822,609 | 1,837,935 | |
| 利潤總額 | 20,714 | -79.57% | (51,826) | 798,326 | 2,543,562 | 1,790,997 | |
| 減：所得稅費用 | 16,541 | -33.76% | 117,407 | 216,735 | 681,092 | 307,396 | |
| 淨利潤 | 4,172 | -94.54% | (169,233) | 581,591 | 1,862,470 | 1,483,601 | |
| 減：非控股權益 | 25,178 | -52.69% | 188,045 | 274,130 | 428,279 | 320,717 | |
| 股東淨利潤 | (21,006) | -190.66% | (357,278) | 307,461 | 1,434,191 | 1,162,884 | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.034 | -192.72% | -0.579 | 0.492 | 2.302 | 1.874 | |
| 每股派息 (元) * | -- | -- | 0.900 | 0.060 | 0.200 | 0.135 | |
| 每股淨資產 (元) * | 10.470 | -12.45% | 10.503 | 12.069 | 11.881 | 9.416 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 05/06/2025 14:20 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
